{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:44:14Z","timestamp":1775119454366,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recall-by-genotype (RbG) research recruits participants previously involved in genetic research based on their genotype. RbG enables the further study of a particular variant of interest, but in recalling participants, it risks disclosing potentially unwanted or distressing genetic information. Any RbG strategy must therefore be done in a manner that addresses the potential ethical and social issues. As part of an RbG pilot on the penetrance of Parkinson\u2019s disease variants, we conducted an empirical mixed-method study with 51 participants of the Cooperative Health Research in South Tyrol (CHRIS) study to understand participant views on RbG research approach. Participants were disclosed the disease under investigation but not the individual variant carrier status. Results showed that participants filtered the information received through personal experience and enacted mechanisms to address the concerns raised by invitation by resorting to personal resources and the support provided by experts. While the non-disclosure of the <jats:italic>Parkin<\/jats:italic> variant carrier status was deemed acceptable, disclosing the disease under study was important for participants. Participant preferences for disclosure of the disease under investigation and the carrier status varied according to how the knowledge of individual carrier status was perceived to impact the participant\u2019s life. This study provided insights into participant response to the RbG research approach, which are relevant for RbG policy development. A suitable communication strategy and granular options addressing preferences for invitation in the original informed consent are critical for an ethically informed RbG policy.<\/jats:p>","DOI":"10.1038\/s41431-022-01277-6","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:04:54Z","timestamp":1672819494000},"page":"1218-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Participant perspective on the recall-by-genotype research approach: a mixed-method embedded study with participants of the CHRIS study"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-9670","authenticated-orcid":false,"given":"Roberta","family":"Biasiotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"K\u00f6sters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5146-3492","authenticated-orcid":false,"given":"Katharina","family":"Tschigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9831-8302","authenticated-orcid":false,"given":"Peter P.","family":"Pramstaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-5986","authenticated-orcid":false,"given":"Max","family":"Borsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2102-3431","authenticated-orcid":false,"given":"Christine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-0411","authenticated-orcid":false,"given":"Andrew A.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-1464","authenticated-orcid":false,"given":"Deborah","family":"Mascalzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"1277_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03109-y","volume":"9","author":"LJ Corbin","year":"2018","unstructured":"Corbin LJ, Tan VY, Hughes DA, Wade KH, Paul DS, Tansey KE, et al. Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference. Nat Commun. 2018;9:711. https:\/\/doi.org\/10.1038\/s41467-018-03109-y.","journal-title":"Nat Commun"},{"key":"1277_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1101\/gr.104455.109","volume":"20","author":"LM Beskow","year":"2010","unstructured":"Beskow LM, Linney KN, Radtke RA, Heinzen EL, Goldstein DB. Ethical challenges in genotype-driven research recruitment. Genome Res. 2010;20:705\u20139. https:\/\/doi.org\/10.1101\/gr.104455.109.","journal-title":"Genome Res"},{"key":"1277_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/15265161.2017.1284916","volume":"17","author":"LM Beskow","year":"2017","unstructured":"Beskow LM. Genotype-driven recruitment and the disclosure of individual research results. Am J Bioeth. 2017;17:64\u20135. https:\/\/doi.org\/10.1080\/15265161.2017.1284916.","journal-title":"Am J Bioeth"},{"key":"1277_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/15265161.2017.1284935","volume":"17","author":"HA Taylor","year":"2017","unstructured":"Taylor HA, Morales C, Wilfond BS. Genotype-Driven Recruitment in population-based biomedical research. Am J Bioeth. 2017;17:58\u20139. https:\/\/doi.org\/10.1080\/15265161.2017.1284935.","journal-title":"Am J Bioeth"},{"key":"1277_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/15265161.2017.1284920","volume":"17","author":"S Doernberg","year":"2017","unstructured":"Doernberg S, Hull SC. Harms of deception in FMR1 premutation genotype-driven recruitment. Am J Bioeth. 2017;17:62\u20133. https:\/\/doi.org\/10.1080\/15265161.2017.1284920.","journal-title":"Am J Bioeth"},{"key":"1277_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00439-012-1177-z","volume":"131","author":"LM Beskow","year":"2012","unstructured":"Beskow LM, Fullerton SM, Namey EE, Nelson DK, Davis AM, Wilfond BS. Recommendations for ethical approaches to genotype-driven research recruitment. Hum Genet. 2012;131:1423\u201331. https:\/\/doi.org\/10.1007\/s00439-012-1177-z.","journal-title":"Hum Genet"},{"key":"1277_CR7","doi-asserted-by":"publisher","unstructured":"Mascalzoni D, Biasiotto R, Borsche M, Bruggemann N, De Grandi A, Goegele M, et al. Balancing scientific interests and the rights of participants in designing a recall by genotype study. Eur J Hum Genet. 2021. https:\/\/doi.org\/10.1038\/s41431-021-00860-7.","DOI":"10.1038\/s41431-021-00860-7"},{"key":"1277_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.parkreldis.2021.03.028","volume":"86","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Borsche M, Hicks AA, Gogele M, Egger C, Kritzinger C, et al. Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls. Parkinsonism Relat Disord. 2021;86:101\u20134. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.028.","journal-title":"Parkinsonism Relat Disord"},{"key":"1277_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0704-9","volume":"13","author":"C Pattaro","year":"2015","unstructured":"Pattaro C, Gogele M, Mascalzoni D, Melotti R, Schwienbacher C, De Grandi A, et al. The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results. J Transl Med. 2015;13:348. https:\/\/doi.org\/10.1186\/s12967-015-0704-9.","journal-title":"J Transl Med"},{"key":"1277_CR10","doi-asserted-by":"publisher","unstructured":"Biasiotto R, Pramstaller PP, Mascalzoni D. The dynamic consent of the Cooperative Health Research in South Tyrol (CHRIS) study: broad aim within specific oversight and communication. BioLaw Journal - Rivista di BioDiritto. 2021(Special Issue 1\/2021):277\u201387. https:\/\/doi.org\/10.15168\/2284-4503-786.","DOI":"10.15168\/2284-4503-786"},{"key":"1277_CR11","doi-asserted-by":"publisher","unstructured":"Mascalzoni D, Melotti R, Pattaro C, Pramstaller PP, G\u00f6gele M, De Grandi A, et al. Ten years of dynamic consent in the CHRIS study: informed consent as a dynamic process. Eur J Hum Genet. 2022. https:\/\/doi.org\/10.1038\/s41431-022-01160-4.","DOI":"10.1038\/s41431-022-01160-4"},{"key":"1277_CR12","unstructured":"Creswell JV, Plano Clark VL. Choosing a mixed methods design. In: Creswell JV, Plano Clark VL (eds). Designing and conducting mixed methods research. SAGE Publications, Thousand Oaks, Calif., 2007. pp 58\u201388."},{"key":"1277_CR13","doi-asserted-by":"publisher","first-page":"204253331347919","DOI":"10.1177\/2042533313479197","volume":"4","author":"S Tariq","year":"2013","unstructured":"Tariq S, Woodman J. Using mixed methods in health research. JRSM Short Rep.2013;4:2042533313479197. https:\/\/doi.org\/10.1177\/2042533313479197.","journal-title":"JRSM Short Rep."},{"key":"1277_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"1277_CR15","doi-asserted-by":"crossref","unstructured":"Terry G, Hayfield N, Clarke V, Braun V. Thematic analysis. In: Willig C and Stainton-Rogers W (eds). The Sage handbook of qualitative research in psychology, 2nd edition. SAGE Publications, Thousand Oaks, Calif., 2017. pp 17\u201337.","DOI":"10.4135\/9781526405555.n2"},{"key":"1277_CR16","unstructured":"Ussher JM (ed). Body talk: the material and discursive regulation of sexuality, madness, and reproduction. Routledge, London, New York, 1997."},{"key":"1277_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/gim.2012.88","volume":"14","author":"M Michie","year":"2012","unstructured":"Michie M, Cadigan RJ, Henderson G, Beskow LM. Am I a control?: Genotype-driven research recruitment and self-understandings of study participants. Genet Med. 2012;14:983\u20139. https:\/\/doi.org\/10.1038\/gim.2012.88.","journal-title":"Genet Med"},{"key":"1277_CR18","doi-asserted-by":"publisher","first-page":"e0202502","DOI":"10.1371\/journal.pone.0202502","volume":"13","author":"JT Minion","year":"2018","unstructured":"Minion JT, Butcher F, Timpson N, Murtagh MJ. The ethics conundrum in Recall by Genotype (RbG) research: Perspectives from birth cohort participants. PLoS One. 2018;13:e0202502. https:\/\/doi.org\/10.1371\/journal.pone.0202502.","journal-title":"PLoS One"},{"key":"1277_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1525\/jer.2011.6.4.41","volume":"6","author":"HK Tabor","year":"2011","unstructured":"Tabor HK, Brazg T, Crouch J, Namey EE, Fullerton SM, Beskow LM, et al. Parent perspectives on pediatric genetic research and implications for genotype-driven research recruitment. J Empir Res Hum Res Ethics. 2011;6:41\u201352. https:\/\/doi.org\/10.1525\/jer.2011.6.4.41.","journal-title":"J Empir Res Hum Res Ethics"},{"key":"1277_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1525\/jer.2011.6.4.30","volume":"6","author":"RJ Cadigan","year":"2011","unstructured":"Cadigan RJ, Michie M, Henderson G, Davis AM, Beskow LM. The meaning of genetic research results: reflections from individuals with and without a known genetic disorder. J Empir Res Hum Res Ethics. 2011;6:30\u201340. https:\/\/doi.org\/10.1525\/jer.2011.6.4.30.","journal-title":"J Empir Res Hum Res Ethics"},{"key":"1277_CR21","doi-asserted-by":"publisher","unstructured":"Staunton C, Kosters M, Pramstaller PP, Mascalzoni D. Return of research results (RoRR) to the healthy CHRIS cohort: designing a policy with the participants. J Community Genet. 2021. https:\/\/doi.org\/10.1007\/s12687-021-00536-1.","DOI":"10.1007\/s12687-021-00536-1"},{"key":"1277_CR22","unstructured":"CHRIS. Studio sulla salute in Alto Adige. Informazioni sullo studio. 2019 [Available from: https:\/\/it.chris.eurac.edu\/wp-content\/uploads\/sites\/11\/2020\/04\/03-25-CHRIS-brochure-IT_2020-002-1.pdf."},{"key":"1277_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1525\/jer.2011.6.4.3","volume":"6","author":"LM Beskow","year":"2011","unstructured":"Beskow LM, Namey EE, Cadigan RJ, Brazg T, Crouch J, Henderson GE, et al. Research participants\u2019 perspectives on genotype-driven research recruitment. J Empir Res Hum Res Ethics. 2011;6:3\u201320. https:\/\/doi.org\/10.1525\/jer.2011.6.4.3.","journal-title":"J Empir Res Hum Res Ethics"},{"key":"1277_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1525\/jer.2011.6.4.21","volume":"6","author":"EE Namey","year":"2011","unstructured":"Namey EE, Beskow LM. Epilepsy patient-participants and genetic research results as \u201canswers\u201d. J Empir Res Hum Res Ethics. 2011;6:21\u20139. https:\/\/doi.org\/10.1525\/jer.2011.6.4.21.","journal-title":"J Empir Res Hum Res Ethics"},{"key":"1277_CR25","first-page":"1","volume":"34","author":"LM Beskow","year":"2012","unstructured":"Beskow LM, Namey EE, Miller PR, Nelson DK, Cooper A. IRB chairs\u2019 perspectives on genotype-driven research recruitment. IRB. 2012;34:1\u201310.","journal-title":"IRB"},{"key":"1277_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.74","volume":"49","author":"R Hilker","year":"2001","unstructured":"Hilker R, Klein C, Ghaemi M, Kis B, Strotmann T, Ozelius LJ, et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the Parkin gene. Ann Neurol. 2001;49:367\u201376. https:\/\/doi.org\/10.1002\/ana.74.","journal-title":"Ann Neurol"},{"key":"1277_CR27","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1093\/brain\/awf237","volume":"125","author":"NL Khan","year":"2002","unstructured":"Khan NL, Brooks DJ, Pavese N, Sweeney MG, Wood NW, Lees AJ, et al. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. Brain. 2002;125:2248\u201356. https:\/\/doi.org\/10.1093\/brain\/awf237.","journal-title":"Brain"},{"key":"1277_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1212\/01.wnl.0000267844.72421.6c","volume":"69","author":"F Binkofski","year":"2007","unstructured":"Binkofski F, Reetz K, Gaser C, Hilker R, Hagenah J, Hedrich K, et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology. 2007;69:842\u201350. https:\/\/doi.org\/10.1212\/01.wnl.0000267844.72421.6c.","journal-title":"Neurology"},{"key":"1277_CR29","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/aws040","volume":"135","author":"S Anders","year":"2012","unstructured":"Anders S, Sack B, Pohl A, Munte T, Pramstaller P, Klein C, et al. Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele. Brain. 2012;135:1128\u201340. https:\/\/doi.org\/10.1093\/brain\/aws040.","journal-title":"Brain"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01277-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01277-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01277-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:03:30Z","timestamp":1698883410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01277-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01277-6","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CK serves as a medical advisor to Centogene for genetic testing reports in the field of movement disorders and dementia, excluding Parkinson\u2019s disease. NB served as a consultant for BridgeBio and Centogene and is member of the scientific advisory board of BridgeBio. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethics committee of the Azienda Sanitaria dell\u2019Alto Adige. Participants provided written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}